Synthetic Biologics' C. difficile drug, ribaxamase, achieved its primary endpoint in a phase 2b trial.
GI & Endoscopy
A study presented at Digestive Disease Week examined how patient genotyping with advanced cirrhosis from hepatitis C virus could help healthcare professionals predict likelihood of improvement after treatment.
A study presented at Digestive Disease Week examined the effectiveness of non-surgical endoscopic sleeve gastroplasty in individuals struggling with obesity who are not candidates for weight loss surgery.
Check-Cap and GE Healthcare achieved their first development milestone when GE's developed and tested X-rays passed all tests to ensure C-scan system compliance.
Takeda Pharmaceuticals reported underlying revenue growth of 6.9 percent from fiscal year 2015 to fiscal year 2016.
Advertisement
Harrisburg (Pa.) Gastroenterology is notifying patients of a potential data breach exposing 93,323 patient records, Healthcare IT News reports.
A study presented at Digestive Disease Week 2017 examined patient satisfaction with irritable bowel syndrome treatment.
Here are six updates on GI companies from the past week.
Masi Khaja, MD, is a gastroenterologist at Grand Junction-based Gastroenterology Associates of Western Colorado.
A study presented at Digestive Disease Week 2017 featured an autonomously controlled capsule robot that could change the public's perception of colonoscopy.